Ethical issues in stem cell research and therapy

Abstract

Rapid progress in biotechnology has introduced a host of pressing ethical and policy issues pertaining to stem cell research. In this review, we provide an overview of the most significant issues with which the stem cell research community should be familiar. We draw on a sample of the bioethics and scientific literatures to address issues that are specific to stem cell research and therapy, as well as issues that are important for stem cell research and therapy but also for translational research in related fields, and issues that apply to all clinical research and therapy. Although debate about the moral status of the embryo in human embryonic stem cell research continues to have relevance, the discovery of other highly multipotent stem cell types and alternative methods of isolating and creating highly multipotent stem cells has raised new questions and concerns. Induced pluripotent stem cells hold great promise, but care is needed to ensure their safety in translational clinical trials, despite the temptation to move quickly from bench to bedside. A variety of highly multipotent stem cells - such as mesenchymal stem/stromal cells and stem cells derived from amniotic fluid, umbilical cord blood, adipose tissue, or urine - present the opportunity for widespread biobanking and increased access. With these increased opportunities, however, come pressing policy issues of consent, control, and justice. The imperatives to minimize risks of harm, obtain informed consent, reduce the likelihood of the therapeutic misconception, and facilitate sound translation from bench to bedside are not unique to stem cell research; their application to stem cell research and therapy nonetheless merits particular attention. Because stem cell research is both scientifically promising and ethically challenging, both the application of existing ethical frameworks and careful consideration of new ethical implications are necessary as this broad and diverse field moves forward.

Efficiency of stem cell based therapy in the treatment of diabetic foot ulcer: a meta-analysis

“…A total of 6 types of stem cells were included in the present analysis. The results that were derived from the study conducted by Dubsky et [34]. To all, the clinical use of stem cells is limited not only because of the issues of safety and efficacy, the political, legal, religion, socioeconomic and ethical factors should also take into consideration.…”

Magnetic induction heating of superparamagnetic nanoparticles during rewarming augments the recovery of hUCM-MSCs cryopreserved by vitrification

“…[8] Thus, hUCM-MSCs are an extremely valuable candidate for cell-based regenerative medicine. [9, 10] Moreover, banking hUCM-MSCs is essential to meet the ever increasing needs of the cells for clinical applications and research [11]. …”

Ethical considerations in tissue engineering research: Case studies in translation

“…For tissue engineering, like other regenerative medicine research, it is most important to address key issues arising in early-stage clinical trials [16–18]. Those issues include: moving into human subjects; designing FIH trials; selecting patient-subjects; and informed consent.…”